{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:00:02Z","timestamp":1784091602497,"version":"3.55.0"},"reference-count":99,"publisher":"European Respiratory Society (ERS)","issue":"167","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2022,12,8]]},"published-print":{"date-parts":[[2023,3,31]]},"abstract":"<jats:p>A significant proportion of COPD patients (\u223c40%) continue smoking despite knowing that they have the disease. Smokers with COPD exhibit higher levels of nicotine dependence, and have lower self-efficacy and self-esteem, which affects their ability to quit smoking. Treatment should be adapted to the needs of individual patients with different levels of tobacco dependence. The combination of counselling plus pharmacotherapy is the most effective cessation treatment for COPD. In patients with severe COPD, varenicline and bupropion have been shown to have the highest abstinence rates compared with nicotine replacement therapy. There is a lack of evidence to support that smoking cessation reduction or harm reduction strategies have benefits in COPD patients. The long-term efficacy and safety of electronic cigarettes for smoking cessation need to be evaluated in high-risk populations; therefore, it is not possible to recommend their use for smoking cessation in COPD. Future studies with the new generation of nicotine vaccines are necessary to determine their effectiveness in smokers in general and in COPD patients.<\/jats:p>","DOI":"10.1183\/16000617.0187-2022","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T09:06:05Z","timestamp":1679475965000},"page":"220187","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Smoking cessation and vaccination"],"prefix":"10.1183","volume":"32","author":[{"given":"Maria","family":"Montes de Oca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia","family":"Laucho-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"2024102404100898000_32.167.220187.1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/19338244.2020.1828243","article-title":"COPD in the major nonsmoking adult: a systematic review and meta-analysis","volume":"76","author":"Cunalata-Paredes","year":"2021","journal-title":"Arch Environ Occup Health"},{"key":"2024102404100898000_32.167.220187.2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1164\/rccm.201710-2028PP","article-title":"At the root: defining and halting progression of early chronic obstructive pulmonary disease","volume":"197","author":"Martinez","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102404100898000_32.167.220187.3","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30100-0"},{"key":"2024102404100898000_32.167.220187.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411532"},{"key":"2024102404100898000_32.167.220187.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1603287"},{"key":"2024102404100898000_32.167.220187.6","first-page":"CD010744","article-title":"Smoking cessation for people with chronic obstructive pulmonary disease","volume":"8","author":"van Eerd","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102404100898000_32.167.220187.7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-4-200502150-00005"},{"key":"2024102404100898000_32.167.220187.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2112096"},{"key":"2024102404100898000_32.167.220187.9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00012704"},{"key":"2024102404100898000_32.167.220187.10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-0930"},{"key":"2024102404100898000_32.167.220187.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201606-1179PP"},{"key":"2024102404100898000_32.167.220187.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01169-7"},{"key":"2024102404100898000_32.167.220187.13","doi-asserted-by":"crossref","first-page":"108256","DOI":"10.1016\/j.neuropharm.2020.108256","article-title":"Nicotinic acetylcholine receptors and nicotine addiction: a brief introduction","volume":"177","author":"Wittenberg","year":"2020","journal-title":"Neuropharmacology"},{"key":"2024102404100898000_32.167.220187.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2007.12.005"},{"key":"2024102404100898000_32.167.220187.15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00213-020-05463-6","article-title":"Differential effects of nicotine delivery rate on subjective drug effects, urges to smoke, heart rate and blood pressure in tobacco smokers","volume":"237","author":"Jensen","year":"2020","journal-title":"Psychopharmacology"},{"key":"2024102404100898000_32.167.220187.16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-022-00346-w","article-title":"Tobacco and nicotine use","volume":"8","author":"Le Foll","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"2024102404100898000_32.167.220187.17","doi-asserted-by":"publisher","DOI":"10.1375\/twin.9.1.64"},{"key":"2024102404100898000_32.167.220187.18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0786"},{"key":"2024102404100898000_32.167.220187.19","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.07111711"},{"key":"2024102404100898000_32.167.220187.20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/cpt.1238","article-title":"Effects of nicotine metabolic rate on withdrawal symptoms and response to cigarette smoking after abstinence","volume":"105","author":"Liakoni","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2024102404100898000_32.167.220187.21","doi-asserted-by":"publisher","DOI":"10.1080\/01677060802572887"},{"key":"2024102404100898000_32.167.220187.22","doi-asserted-by":"publisher","DOI":"10.1080\/14622200701239605"},{"key":"2024102404100898000_32.167.220187.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0307-5"},{"key":"2024102404100898000_32.167.220187.24","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-12-9"},{"key":"2024102404100898000_32.167.220187.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67632-5"},{"key":"2024102404100898000_32.167.220187.26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S2213-2600(18)30103-6","article-title":"Chronic obstructive pulmonary disease in China: a nationwide prevalence study","volume":"6","author":"Fang","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102404100898000_32.167.220187.27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3109\/15412555.2014.898049","article-title":"Smoking prevalence and cessation characteristics among U.S. adults with and without COPD: findings from the 2011 Behavioral Risk Factor Surveillance System","volume":"11","author":"Schauer","year":"2014","journal-title":"COPD"},{"key":"2024102404100898000_32.167.220187.28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arbres.2020.07.024","article-title":"Prevalence and determinants of COPD in Spain: EPISCAN II","volume":"57","author":"Soriano","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"2024102404100898000_32.167.220187.29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/COPD.S279315","article-title":"Predicting re-exacerbation timing and understanding prolonged exacerbations: an analysis of patients with COPD in the ECLIPSE cohort","volume":"16","author":"Meeraus","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102404100898000_32.167.220187.30","first-page":"64","article-title":"Mortality and exacerbations by global initiative for chronic obstructive lung disease groups ABCD: 2011 versus 2017 in the COPDGene cohort","volume":"6","author":"Criner","year":"2019","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2024102404100898000_32.167.220187.31","first-page":"27","article-title":"Characteristics of COPD patients treated with single-inhaler triple therapy in real-life clinical practice","volume":"123","author":"Lassan","year":"2022","journal-title":"Bratisl Lek Listy"},{"key":"2024102404100898000_32.167.220187.32","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2147\/COPD.S159827","article-title":"Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA","volume":"13","author":"Kardos","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102404100898000_32.167.220187.33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.rmed.2015.12.010","article-title":"The \u2018real-life\u2019 COPD patient in Germany: the DACCORD study","volume":"111","author":"Worth","year":"2016","journal-title":"Respir Med"},{"key":"2024102404100898000_32.167.220187.34","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(16)30069-1","article-title":"Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial","volume":"387","author":"Vestbo","year":"2016","journal-title":"Lancet"},{"key":"2024102404100898000_32.167.220187.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31354-X"},{"key":"2024102404100898000_32.167.220187.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30188-5"},{"key":"2024102404100898000_32.167.220187.37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2213-2600(18)30102-4","article-title":"Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial","volume":"6","author":"Calverley","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024102404100898000_32.167.220187.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30206-X"},{"key":"2024102404100898000_32.167.220187.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713901"},{"key":"2024102404100898000_32.167.220187.40","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30327-8"},{"key":"2024102404100898000_32.167.220187.41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916046"},{"key":"2024102404100898000_32.167.220187.42","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03338-2020"},{"key":"2024102404100898000_32.167.220187.43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12931-021-01683-2","article-title":"Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial","volume":"22","author":"Zheng","year":"2021","journal-title":"Respir Res"},{"key":"2024102404100898000_32.167.220187.44","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.064410"},{"key":"2024102404100898000_32.167.220187.45","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.5.1365"},{"key":"2024102404100898000_32.167.220187.46","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246161"},{"key":"2024102404100898000_32.167.220187.47","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00010604"},{"key":"2024102404100898000_32.167.220187.48","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.2.334"},{"key":"2024102404100898000_32.167.220187.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.04.016"},{"key":"2024102404100898000_32.167.220187.50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04724-3"},{"key":"2024102404100898000_32.167.220187.51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.rmed.2014.01.007","article-title":"Smoking cessation effectiveness in smokers with COPD and asthma under real life conditions","volume":"108","author":"Gratziou","year":"2014","journal-title":"Respir Med"},{"key":"2024102404100898000_32.167.220187.52","doi-asserted-by":"publisher","DOI":"10.1080\/02813430600819751"},{"key":"2024102404100898000_32.167.220187.53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.18332\/tid\/90665","article-title":"Factors associated with current smoking in COPD patients: a cross-sectional study from the Eastern Black Sea region of Turkey","volume":"16","author":"Karadogan","year":"2018","journal-title":"Tob Induc Dis"},{"key":"2024102404100898000_32.167.220187.54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.18332\/tid\/142848","article-title":"Characteristics of and reasons for patients with chronic obstructive pulmonary disease to continue smoking, quit smoking, and switch to heated tobacco products","volume":"19","author":"Hirai","year":"2021","journal-title":"Tob Induc Dis"},{"key":"2024102404100898000_32.167.220187.55","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.51.3.390"},{"key":"2024102404100898000_32.167.220187.56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb01879.x"},{"key":"2024102404100898000_32.167.220187.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2004.03.019"},{"key":"2024102404100898000_32.167.220187.58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001292.pub3"},{"key":"2024102404100898000_32.167.220187.59","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00167708"},{"key":"2024102404100898000_32.167.220187.60","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.131631"},{"key":"2024102404100898000_32.167.220187.61","doi-asserted-by":"publisher","DOI":"10.1080\/14622200601078509"},{"key":"2024102404100898000_32.167.220187.62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.18332\/tid\/106090","article-title":"Spirometry to increase smoking cessation rate: a systematic review","volume":"17","author":"Westerdahl","year":"2019","journal-title":"Tob Induc Dis"},{"key":"2024102404100898000_32.167.220187.63","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/14656566.2020.1858796","article-title":"Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review","volume":"22","author":"Antoniu","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"2024102404100898000_32.167.220187.64","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5603\/ARM.28222","article-title":"Wyniki leczenia uzaleznienia od nikotyny chorych na przewlek\u0142a obturacyjna chorob\u00e9 p\u0142uc. [Effect of treatment for nicotine dependence in patients with COPD.]","volume":"71","author":"Gorecka","year":"2003","journal-title":"Pneumonol Alergol Pol"},{"key":"2024102404100898000_32.167.220187.65","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/nts001"},{"key":"2024102404100898000_32.167.220187.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2010.04.009"},{"key":"2024102404100898000_32.167.220187.67","first-page":"CD013183","article-title":"Smoking reduction interventions for smoking cessation","volume":"9","author":"Lindson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102404100898000_32.167.220187.68","first-page":"CD005231","article-title":"Interventions to reduce harm from continued tobacco use","volume":"10","author":"Lindson-Hawley","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102404100898000_32.167.220187.69","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01815-2019"},{"key":"2024102404100898000_32.167.220187.70","first-page":"CD010216","article-title":"Electronic cigarettes for smoking cessation","volume":"9","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102404100898000_32.167.220187.71","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ccm.2020.06.013","article-title":"Smoking cessation\/vaccinations","volume":"41","author":"Montes de Oca","year":"2020","journal-title":"Clin Chest Med"},{"key":"2024102404100898000_32.167.220187.72","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-016-0481-x"},{"key":"2024102404100898000_32.167.220187.73","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S161138"},{"key":"2024102404100898000_32.167.220187.74","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11606-017-4150-7","article-title":"Electronic cigarette use in US adults at risk for or with COPD: analysis from two observational cohorts","volume":"32","author":"Bowler","year":"2017","journal-title":"J Gen Intern Med"},{"key":"2024102404100898000_32.167.220187.75","doi-asserted-by":"crossref","first-page":"e2020816","DOI":"10.1001\/jamanetworkopen.2020.20816","article-title":"Association of electronic cigarette use with incident respiratory conditions among US adults from 2013 to 2018","volume":"3","author":"Xie","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024102404100898000_32.167.220187.76","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-208039"},{"key":"2024102404100898000_32.167.220187.77","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S157728"},{"key":"2024102404100898000_32.167.220187.78","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-016-0368-x"},{"key":"2024102404100898000_32.167.220187.79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116732"},{"key":"2024102404100898000_32.167.220187.80","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-016-1378-3"},{"key":"2024102404100898000_32.167.220187.81","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201708-1590OC"},{"key":"2024102404100898000_32.167.220187.82","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1513\/AnnalsATS.202009-1113CME","article-title":"Harms of electronic cigarettes: what the healthcare provider needs to know","volume":"18","author":"Farber","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2024102404100898000_32.167.220187.83","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.3390\/ijerph18084079","article-title":"Lung damage caused by heated tobacco products and electronic nicotine delivery systems: a systematic review","volume":"18","author":"Bravo-Gutierrez","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2024102404100898000_32.167.220187.84","doi-asserted-by":"crossref","first-page":"120098","DOI":"10.1016\/j.jns.2021.120098","article-title":"Current status of vaccines for substance use disorders: a brief review of human studies","volume":"434","author":"Truong","year":"2022","journal-title":"J Neurol Sci"},{"key":"2024102404100898000_32.167.220187.85","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.004234"},{"key":"2024102404100898000_32.167.220187.86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805942105"},{"key":"2024102404100898000_32.167.220187.87","first-page":"1","article-title":"Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine","volume":"234","author":"Henningfield","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"2024102404100898000_32.167.220187.88","first-page":"CD007072","article-title":"Nicotine vaccines for smoking cessation","volume":"8","author":"Hartmann-Boyce","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102404100898000_32.167.220187.89","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.317"},{"key":"2024102404100898000_32.167.220187.90","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.biomaterials.2016.08.028","article-title":"The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine","volume":"106","author":"Hu","year":"2016","journal-title":"Biomaterials"},{"key":"2024102404100898000_32.167.220187.91","unstructured":"World Health Organization . WHO Coronavirus (COVID-19) Dashboard. 2022. https:\/\/covid19.who.int Date last accessed: 16 December 2022."},{"key":"2024102404100898000_32.167.220187.92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233147"},{"key":"2024102404100898000_32.167.220187.93","doi-asserted-by":"crossref","first-page":"246","DOI":"10.52586\/4938","article-title":"Key toolkits of non-pharmacological management in COPD: during and beyond COVID-19","volume":"26","author":"Alqahtani","year":"2021","journal-title":"Front Biosci"},{"key":"2024102404100898000_32.167.220187.94","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000817"},{"key":"2024102404100898000_32.167.220187.95","doi-asserted-by":"crossref","first-page":"941575","DOI":"10.3389\/fpsyt.2022.941575","article-title":"The impact of the COVID-19 pandemic on smoking consumption: a systematic review of longitudinal studies","volume":"13","author":"Almeda","year":"2022","journal-title":"Front Psychiatry"},{"key":"2024102404100898000_32.167.220187.96","unstructured":"World Health Organization . Coronavirus Disease (COVID-19): Tobacco. 2022. www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/question-and-answers-hub\/q-a-detail\/coronavirus-disease-covid-19-tobacco Date last accessed: 16 December 2022."},{"key":"2024102404100898000_32.167.220187.97","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/vaccines9091042","article-title":"Age and smoking predict antibody titres at 3\u2005months after the second dose of the BNT162b2 COVID-19 vaccine","volume":"9","author":"Nomura","year":"2021","journal-title":"Vaccines"},{"key":"2024102404100898000_32.167.220187.98","doi-asserted-by":"crossref","first-page":"e3465","DOI":"10.1002\/dmrr.3465","article-title":"Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine","volume":"38","author":"Watanabe","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"2024102404100898000_32.167.220187.99","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400055790"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0187-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:05:44Z","timestamp":1740373544000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0187-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":99,"journal-issue":{"issue":"167","published-online":{"date-parts":[[2023,3,22]]},"published-print":{"date-parts":[[2023,3,31]]}},"alternative-id":["10.1183\/16000617.0187-2022"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0187-2022","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]}}}